Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022


  • Products Id :- LI 161715
  • |
  • Pages: 202
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose. Linked wirelessly to the cloud, smart inhalers are a part of Internet of Things, thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of the dose, which can be recorded for understanding the patient's daily routine.

The world smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Under the moderate growth scenario, smart inhalers market is estimated to reach $191 million by 2022, growing at a CAGR of 63.3% during 2016 to 2022. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, due to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor for the growth of smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance towards adoption of smart inhalers are expected to hinder the market growth.

The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD. On the basis of end user, it is divided into patients and R&D. In terms of geography, the market is analyzed into North America, Europe, Asia-Pacific, and LAMEA.

North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the highest CAGR of 65.3%, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.

Companies have adopted product approval and clinical trials as their key development strategies. Increase in focus on clinical trials is mainly for the development of innovative technologies in the field of smart inhalers. In March 2016, Adherium received a product approval to sell its SmartTurbo and SmartTouch devices in Canada, thereby expanding its product portfolio.

Key players operating in the market include:

Adherium Limited

Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)

Propeller Health

Cohero Health, LLC

OPKO Health, Inc. (Inspiro Medical Ltd.)

GlaxoSmithKline plc

Novartis AG

AstraZeneca plc

Boehringer Ingelheim GmbH

Vectura Group plc

KEY BENEFITS FOR STAKEHOLDERS:

The report provides an in-depth analysis of the estimated revenues generated by smart inhalers as well as major geographies during the forecast period.

The report presents three different market scenarios for smart inhalers, both for value and volume, based on rapid growth, diminishing growth, and moderate growth scenarios.

Quantitative analysis of the current market and estimations from 2016 to 2022 is presented to help the manufacturers of smart inhalers to analyze the market.

Entire projections presented in the report highlight the market potential, both in terms of value and volume.

The report conducts extensive analysis of the market by closely following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS:

By Product

Inhalers

Dry Powder Inhalers (DPIs)

Metered Dose Inhalers (MDIs)

Nebulizers

By Indication

Asthma

COPD

By End User

Patients

R&D

By Geography

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Russia

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia-Pacific

LAMEA

Brazil

Turkey

Saudi Arabia

UAE

Rest of LAMEA



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

CHAPTER 1 INTRODUCTION

1.1 Report Description

1.2 Key Benefits

1.3 Key Market Segments

1.4 Research Methodology

1.4.1 Secondary Research

1.4.2 Primary Research

1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope

3.2 Key Findings

3.2.1 Top Winning Strategies

3.2.2 Top Investment Pockets

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Suppliers

3.3.2 Bargaining Power of Buyers

3.3.3 Threat of Substitutes

3.3.4 Threat of New Entrants

3.3.5 Intensity of Competitive Rivalry

3.4 Top Player Positioning, 2015

3.5 Clinical Trials

3.6 Product Portfolio

3.7 Market Dynamics

3.7.1 Drivers

3.7.1.1 Global increase in air pollution

3.7.1.2 Increase in population susceptible to indoor air pollutants

3.7.1.3 Increasing prevalence of COPD and asthma globally

3.7.1.4 Expected increase in adherence to smart inhalers

3.7.1.5 Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers

3.7.1.6 Rising incidences of chronic conditions

3.7.2 Restraints

3.7.2.1 Misusing data and data privacy

3.7.2.2 Availability of smart inhalers

3.7.2.3 Overall high cost of asthma and COPD treatment

3.7.2.4 Resistance towards adoption of smart inhalers

3.7.3 Opportunities

3.7.3.1 Increased focus towards advanced treatment protocols

3.7.3.2 Significant unmet need in respiratory care

3.7.3.3 Increased awareness to reduce healthcare costs

3.7.3.4 Opportunities in emerging economies

CHAPTER 4 SMART INHALERS MARKET, BY PRODUCT, 2014-2022

4.1 Overview

4.1.1 Market Size and Forecast

4.2 Inhalers

4.2.1 Key Market Trends

4.2.2 Growth Factors and Opportunities

4.2.3 Market Size and Forecast

4.2.4 Dry Powder Inhalers (DPIs)

4.2.5 Metered Dose Inhalers (MDIs)

4.3 Nebulizers

4.3.1 Key Market Trends

4.3.2 Growth Factors and Opportunities

4.3.3 Market Size and Forecast

CHAPTER 5 SMART INHALERS MARKET, BY INDICATION, 2014-2022

5.1 Overview

5.1.1 Market Size and Forecast

5.2 Asthma

5.2.1 Market Size and Forecast

5.3 COPD

5.3.1 Market Size and Forecast

CHAPTER 6 SMART INHALERS MARKET, BY END USER, 2014-2022

6.1 Overview

6.1.1 Market Size and Forecast

6.2 Patients

6.2.1 Market Size and Forecast

6.3 R&D

6.3.1 Market Size and Forecast

CHAPTER 7 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022

7.1 Overview

7.1.1 Market Size and Forecast

7.2 North America

7.2.1 Key Market Trends

7.2.2 Growth Factors and Opportunities

7.2.3 Market Size and Forecast

7.2.3.1 U.S.: Market Size and Forecast

7.2.3.2 Canada: Market Size and Forecast

7.2.3.3 Mexico: Market Size and Forecast

7.3 Europe

7.3.1 Key Market Trends

7.3.2 Growth Factors and Opportunities

7.3.3 Market Size and Forecast

7.3.3.1 Germany: Market Size and Forecast

7.3.3.2 UK: Market Size and Forecast

7.3.3.3 France: Market Size and Forecast

7.3.3.4 Italy: Market Size and Forecast

7.3.3.5 Russia: Market Size and Forecast

7.4 Asia-Pacific

7.4.1 Key Market Trends

7.4.2 Growth Factors and Opportunities

7.4.3 Market Size and Forecast

7.4.3.1 Japan: Market Size and Forecast

7.4.3.2 China: Market Size and Forecast

7.4.3.3 India: Market Size and Forecast

7.4.3.4 Australia: Market Size and Forecast

7.4.3.5 Rest of Asia-Pacific: Market Size and Forecast

7.5 LAMEA (Latin America, Middle East, and Africa)

7.5.1 Key Market Trends

7.5.2 Growth Factors and Opportunities

7.5.3 Market Size and Forecast

7.5.3.1 Brazil: Market Size and Forecast

7.5.3.2 Turkey: Market Size and Forecast

7.5.3.3 Saudi Arabia: Market Size and Forecast

7.5.3.4 UAE: Market Size and Forecast

7.5.3.5 Rest of Lamea: Market Size and Forecast

CHAPTER 8 COMPANY PROFILES

8.1 Adherium Limited

8.1.1 Company Overview

8.1.2 Company Snapshot

8.1.3 Operating Business Segments

8.1.4 Business Performance

8.1.5 Key Strategic Moves and Developments

8.2 Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)

8.2.1 Company Overview

8.2.2 Company Snapshot

8.2.3 Operating Business Segments

8.2.4 Business Performance

8.2.5 Key Strategic Moves and Developments

8.3 Propeller Health

8.3.1 Company Overview

8.3.2 Company Snapshot

8.3.3 Operating Business Segments

8.3.4 Business Performance

8.3.5 Key Strategic Moves and Developments

8.4 Cohero Health, LLC

8.4.1 Company Overview

8.4.2 Company Snapshot

8.4.3 Operating Business Segments

8.4.4 Business Performance

8.4.5 Key Strategic Moves and Developments

8.5 OPKO Health, Inc. (Inspiro Medical Ltd.)

8.5.1 Company Overview

8.5.2 Company Snapshot

8.5.3 Operating Business Segments

8.5.4 Business Performance

8.5.5 Key Strategic Moves and Developments

8.6 GlaxoSmithKline plc

8.6.1 Company Overview

8.6.2 Operating Business Segments

8.6.3 Business Performance

8.6.4 Key Strategic Moves and Developments

8.7 Novartis AG

8.7.1 Company Overview

8.7.2 Operating Business Segments

8.7.3 Business Performance

8.7.4 Key Strategic Moves and Developments

8.8 AstraZeneca plc

8.8.1 Company Overview

8.8.2 Operating Business Segments

8.8.3 Business Performance

8.8.4 Key Strategic Moves and Developments

8.9 Boehringer Ingelheim GmbH

8.9.1 Company Overview

8.9.2 Operating Business Segments

8.9.3 Business Performance

8.9.4 Key Strategic Moves and Developments

8.10 Vectura Group plc

8.10.1 Company Overview

8.10.2 Company Snapshot

8.10.3 Operating Business Segments

8.10.4 Business Performance

8.10.5 Key Strategic Moves and Developments

List of Figures

FIG. 1 PRIMARY RESPONDENTS: % SPLIT

FIG. 2 SMART INHALERS MARKET: SEGMENTATION

FIG. 3 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION

FIG. 4 TOP WINNING STRATEGIES: NATURE & TYPE

FIG. 5 TYPES OF STRATEGIES DISTRIBUTION

FIG. 6 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES

FIG. 7 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES

FIG. 8 TOP INVESTMENT POCKETS: WORLD SMART INHALERS, BY REGION

FIG. 9 PORTERS FIVE FORCES ANALYSIS

FIG. 10 TOP PLAYER POSITIONING, 2015

FIG. 11 TOP IMPACTING FACTORS: SMART INHALERS MARKET, 20152022

FIG. 12 ASTHMA: MAJOR INFLUENCING FACTORS

FIG. 13 ASTHMA: ECONOMIC BURDEN

FIG. 14 GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD) CLASSIFICATION OF COPD

FIG. 15 COPD: MAJOR CAUSES

FIG. 16 U.S.: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 17 U.S.: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 18 CANADA: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 19 CANADA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 20 MEXICO: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 21 MEXICO: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 22 GERMANY: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 23 GERMANY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 24 UK: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 25 UK: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 26 FRANCE: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 27 FRANCE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 28 ITALY: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 29 ITALY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 30 RUSSIA: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 31 RUSSIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 32 REST OF EUROPE: MARKET SIZE AND FORECAST

FIG. 33 REST OF EUROPE: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 34 REST OF EUROPE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 35 JAPAN: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 36 JAPAN: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 37 CHINA: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 38 CHINA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 39 INDIA: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 40 INDIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 41 AUSTRALIA: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 42 AUSTRALIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 43 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 44 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 45 BRAZIL: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 46 BRAZIL: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 47 TURKEY: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 48 TURKEY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 49 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 50 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 51 UAE: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 52 UAE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 53 REST OF LAMEA: SMART INHALERS MARKET SIZE, 20142022 ($000)

FIG. 54 REST OF LAMEA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)

FIG. 55 ADHERIUM: NET REVENUE, 20142015 ($MILLION)

FIG. 56 ADHERIUM: STRATEGY SHARE, 20152016 (%)

FIG. 57 TEVA: REVENUE, 20132015 ($MILLION)

FIG. 58 TEVA: REVENUE, BY PRODUCT TYPE, 2015 (%)

FIG. 59 PROPELLER HEALTH: STRATEGY SHARE, 20152016 (%)

FIG. 60 COHERO HEALTH: STRATEGY SHARE, 20142016 (%)

FIG. 61 OPKO HEALTH: REVENUE, 20132015 ($MILLION)

FIG. 62 OPKO HEALTH: REVENUE, BY SEGMENT, 2015 (%)

FIG. 63 OPKO HEALTH: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 64 OPKO HEALTH: STRATEGY SHARE, 20132014 (%)

FIG. 65 GSK: REVENUE, 20132015 ($MILLION)

FIG. 66 GSK: REVENUE, BY SEGMENT, 2015 (%)

FIG. 67 GSK: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 68 GSK: STRATEGY SHARE, 20132015 (%)

FIG. 69 NOVARTIS: REVENUE, 20132015 ($MILLION)

FIG. 70 NOVARTIS: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 71 NOVARTIS: REVENUE, BY SEGMENT, 2015 (%)

FIG. 72 NOVARTIS: STRATEGY SHARE, 20132015 (%)

FIG. 73 ASTRAZENECA: REVENUE, 20132015 ($MILLION)

FIG. 74 ASTRAZENECA: REVENUE, BY SEGMENT, 2015 (%)

FIG. 75 ASTRAZENECA: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 76 ASTRAZENECA: STRATEGY SHARE, 20142016 (%)

FIG. 77 BOEHRINGER INGELHEIM: REVENUE, 20132015 ($MILLION)

FIG. 78 BOEHRINGER INGELHEIM: REVENUE, BY SEGMENT, 2015 (%)

FIG. 79 BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 80 BOEHRINGER INGELHEIM: STRATEGY SHARE, 20142016 (%)

FIG. 81 VECTURA: REVENUE, 20132015 ($MILLION)

FIG. 82 VECTURA: REVENUE, BY GEOGRAPHY, 2015 (%)

TABLE 1 CLINICAL TRIALS: SMART INHALERS

TABLE 2 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO

TABLE 3 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO

TABLE 4 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO

TABLE 5 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 6 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 7 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 8 INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO

TABLE 9 INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO

TABLE 10 INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO

TABLE 11 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO

TABLE 12 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 13 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO

TABLE 14 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 15 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 16 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 17 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 18 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 19 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 20 DPIS: TYPES

TABLE 21 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO

TABLE 22 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 23 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO

TABLE 24 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 25 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 26 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 27 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO

TABLE 28 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO

TABLE 29 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO

TABLE 30 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 31 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 32 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 33 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO

TABLE 34 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 35 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO

TABLE 36 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 37 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 38 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 39 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO

TABLE 40 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 41 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO

TABLE 42 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 43 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 44 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 45 SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO

TABLE 46 SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO

TABLE 47 SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO

TABLE 48 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 49 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 50 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 51 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO

TABLE 52 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 53 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO

TABLE 54 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 55 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 56 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 57 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO

TABLE 58 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 59 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO

TABLE 60 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 61 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 62 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 63 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO

TABLE 64 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 65 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO

TABLE 66 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 67 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 68 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 69 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO

TABLE 70 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO

TABLE 71 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO

TABLE 72 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 73 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 74 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 75 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO

TABLE 76 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO

TABLE 77 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO

TABLE 78 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 79 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 80 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 81 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO

TABLE 82 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO

TABLE 83 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO

TABLE 84 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 85 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 86 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 87 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO

TABLE 88 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 89 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO

TABLE 90 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 91 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 92 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 93 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO

TABLE 94 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO

TABLE 95 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO

TABLE 96 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 97 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 98 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 99 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO

TABLE 100 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO

TABLE 101 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO

TABLE 102 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 103 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 104 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 105 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO

TABLE 106 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO

TABLE 107 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO

TABLE 108 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 109 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 110 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 111 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO

TABLE 112 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 113 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO

TABLE 114 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 115 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 116 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 117 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO

TABLE 118 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO

TABLE 119 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO

TABLE 120 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 121 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 122 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 123 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO

TABLE 124 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO

TABLE 125 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO

TABLE 126 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 127 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 128 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 129 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO

TABLE 130 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO

TABLE 131 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO

TABLE 132 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 133 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 134 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 135 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO

TABLE 136 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 137 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO

TABLE 138 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 139 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 140 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 141 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO

TABLE 142 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO

TABLE 143 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO

TABLE 144 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 145 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 146 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 147 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO

TABLE 148 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO

TABLE 149 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO

TABLE 150 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 151 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 152 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 153 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO

TABLE 154 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO

TABLE 155 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO

TABLE 156 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 157 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 158 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 159 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO

TABLE 160 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO

TABLE 161 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO

TABLE 162 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO

TABLE 163 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO

TABLE 164 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO

TABLE 165 ADHERIUM: COMPANY SNAPSHOT

TABLE 166 ADHERIUM: OPERATING SEGMENTS

TABLE 167 TEVA: COMPANY SNAPSHOT

TABLE 168 TEVA: OPERATING SEGMENTS

TABLE 169 PROPELLER HEALTH: COMPANY SNAPSHOT

TABLE 170 PROPELLER HEALTH: OPERATING SEGMENTS

TABLE 171 COHERO HEALTH: COMPANY SNAPSHOT

TABLE 172 COHERO HEALTH: OPERATING SEGMENTS

TABLE 173 OPKO HEALTH: COMPANY SNAPSHOT

TABLE 174 OPKO HEALTH: OPERATING SEGMENTS

TABLE 175 GSK: COMPANY SNAPSHOT

TABLE 176 GSK: OPERATING SEGMENTS

TABLE 177 NOVARTIS: COMPANY SNAPSHOT

TABLE 178 NOVARTIS: OPERATING SEGMENTS

TABLE 179 ASTRAZENECA: COMPANY SNAPSHOT

TABLE 180 ASTRAZENECA: OPERATING SEGMENTS

TABLE 181 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT

TABLE 182 BOEHRINGER INGELHEIM: OPERATING SEMENTS

TABLE 183 VECTURA: COMPANY SNAPSHOT

TABLE 184 VECTURA: OPERATING SEGMENTS

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Adherium Limited

Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)

Propeller Health

Cohero Health, LLC

OPKO Health, Inc. (Inspiro Medical Ltd.)

GlaxoSmithKline plc

Novartis AG

AstraZeneca plc

Boehringer Ingelheim GmbH

Vectura Group plc

select a license

Single User License
USD 4740 INR 303739
Corporate User License
USD 8250 INR 528660

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com